부산대학교 도서관

Gribkoff, VK; Pieschl, RL; Wisialowski, TA; Park, WK; Strecker, GJ; de Jeu, MTG; Pennartz, CMA; Dudek, FE

JOURNAL OF BIOLOGICAL RHYTHMS; APR 1999, 14 2, p126-p130, 5p.

Gribkoff, VK; Pieschl, RL; Wisialowski, TA; van den Pol, AN; Yocca, FD

JOURNAL OF NEUROSCIENCE; APR 15 1998, 18 8, p3014-p3022, 9p.

VORPERIAN, VR; WISIALOWSKI, TA; DEEGAN, R; RODEN, DM

CIRCULATION; JUL 1994, 90 1, p456-p461, 6p.

TURGEON, J; WISIALOWSKI, TA; WONG, W; ALTEMEIER, WA; WIKSWO, JP; RODEN, DM

CIRCULATION; JUN 1992, 85 6, p2221-p2226, 6p.

WIKSWO, JP; WISIALOWSKI, TA; ALTEMEIER, WA; BALSER, JR; KOPELMAN, HA; RODEN, DM

CIRCULATION RESEARCH; FEB 1991, 68 2, p513-p530, 18p.

Chaudhary KW; Bristol Myers Squibb, New Brunswick, New Jersey, USA.; Clancy CE; Department of Physiology and Membrane Biology, University of California Davis, Davis, California, USA.; Yang PC; Department of Physiology and Membrane Biology, University of California Davis, Davis, California, USA.; Pierson JB; HESI, Washington, DC, USA.; Goldin AL; University of California, Irvine, Irvine, California, USA.; Koerner JE; Independent, San Diego, California, USA.; Wisialowski TA; Pfizer, Groton, Connecticut, USA.; Valentin JP; UCB Biopharma SRL, Braine-l'Alleud, Belgium.; Imredy JP; Merck & Co., Inc., Rahway, New Jersey, USA.; Lagrutta A; Merck & Co., Inc., Rahway, New Jersey, USA.; Authier S; Charles River Laboratories, Laval, Quebec, Canada.; Kleiman R; Clario, Philadelphia, Pennsylvania, USA.; Sager PT; Stanford University, Palo Alto, California, USA.; Hoffmann P; Independent, Beaufort, South Carolina, USA.; Pugsley MK; Cytokinetics, South San Francisco, California, USA.

Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Rossman EI; GSK, Nonclinical Safety, Safety Pharmacology, Collegeville, PA, USA. Electronic address: eric.i.rossman@gsk.com.; Wisialowski TA; Pfizer Worldwide Research Development and Medical, Safety Pharmacology, Groton, CT, USA.; Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA.; Valentin JP; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium; Clario, Philadelphia, PA, USA.; Rolf MG; AstraZeneca, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden.; Roche BM; Charles River Laboratories, Global Safety Pharmacology, Ashland, OH, USA.; Riley S; Pfizer Worldwide Research Development and Medical, Clinical Pharmacology, Groton, CT, USA.; Pugsley MK; Cytokinetics, Toxicology, South San Francisco, CA, USA.; Nicholsi J; Labcorp Early Development Laboratories Inc., Madison, WI, USA.; Li D; Pfizer Global Product Development, Global Biometrics & Data Management, Groton, CT, USA.; Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA.; Kleiman RB; Clario, Philadelphia, PA, USA.; Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Gintant GA; NuPharma Consulting, LLC, USA.; Engwall MJ; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA.; Delaunois A; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.; Authier S; Charles River Laboratories, Laval, QC, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE; In Process

Valentin JP; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: jean-pierre.valentin@ucb.com.; Bourcier T; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.; Todd Bourcier Current Contact Information is 'White Oak Regulatory Tox, LLC, Crownsville, MD 21032, USA.. Electronic address: todd.bourcier@whiteoakregtox.com.; Chi X; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.. Electronic address: Xuan.Chi@fda.hhs.gov.; Delaunois A; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: annie.delaunois@ucb.com.; Foley CM; Preclinical Safety/Safety Pharmacology, AbbVie Inc., North Chicago, IL 60064, USA.. Electronic address: michael.foley@abbvie.com.; Henderson KA; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.. Electronic address: khende02@amgen.com.; Lainee P; Sanofi Research and Development, Translational Models, Montpellier, France.. Electronic address: pierre.lainee@sanofi.com.; Leishman DJ; Drug Disposition, Toxicology and PKPD, Eli Lilly and Company, Indianapolis, IN 46285, USA.. Electronic address: derek.leishman@lilly.com.; Li D; Pfizer Research and Development, Eastern Point Road, Groton, CT 06340, USA.. Electronic address: dingzhou.li@pfizer.com.; Pawluk E; Early Clinical Development & Translational Science, Non-Clinical Safety Evaluation, UCB, Braine L'Alleud, Belgium. Electronic address: emma.pawluk@ucb.com.; Pugsley MK; Cytokinetics, Toxicology & Safety Pharmacology, South San Francisco, CA 85024, USA.. Electronic address: mpugsley@cytokinetics.com.; Rajamani S; Johnson & Johnson Innovative Medicine, 3120 Merryfield Row, San Diego, CA 92121, USA.. Electronic address: srajama3@its.jnj.com.; Regan CP; Nonclinical Drug Safety Merck & Co., Inc., Rahway, NJ 07065, USA.. Electronic address: christopher_regan@merck.com.; Rolf MG; AstraZeneca R&D, Pepparedsleden 1, 431 83 Mölndal, Sweden. Electronic address: mike.rolf@astrazeneca.com.; Ross R; Labcorp, Madison, WI 53704, USA.. Electronic address: rebecca.ross@labcorp.com.; Rossman EI; GSK, Safety Pharmacology, Collegeville, PA 19426, USA.. Electronic address: eric.i.rossman@gsk.com.; Tichenor SD; Charles River Laboratories, 6995 Longley Lane, Reno, NV 89511, USA.. Electronic address: steve.tichenor@crl.com.; Villar IC; AstraZeneca R&D, The Discovery Centre, 1 Francis Crick Avenue, Cambridge CB20AA, UK. Electronic address: conchi.villarmoas@astrazeneca.com.; Wisialowski TA; Pfizer Research and Development, Eastern Point Road, Groton, CT 06340, USA.. Electronic address: todd.a.wisialowski@pfizer.com.; Wu J; Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.. Electronic address: jean.wu@fda.hhs.gov.; Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.. Electronic address: hvargas@amgen.com.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE

Friedrichs GS; Novartis Biomedical Research, 1 Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: greg.friedrichs@novartis.com.; Abernathy MM; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA.; Ackley D; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA.; Clark M; Ability Biologics, 3 Place Ville-Marie Suite 400, Montréal, Québec H3B 4W8, Canada.; DaSilva JK; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA.; Foley CM; Abbvie Inc, North Chicago, IL, 60064, USA.; Greiter-Wilke A; Roche Innovation Center Basel, Grenzacherstr. 124, CH 4070 Basel, Switzerland.; Henderson KA; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.; Kremer JJ; Novartis BioMedical Research, 220 Massachusetts Avenue, Cambridge, MA 02139, USA.; Morimoto BH; Alto Neuroscience, Inc. 369 S San Antonio Rd, Los Altos CA 94022, USA.; Paglialunga S; Celerion, 2420 W Baseline Rd, Tempe, AZ 85283, USA.; Pugsley MK; Cytokinetics, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA.; Regan CP; Merck & Co., Inc., West Point, PA 19486, USA.; Rossman EI; GSK, 1250 Collegeville Avenue, Collegeville, PA 19426, USA.; Segretti JA; Abbvie Inc, North Chicago, IL, 60064, USA.; Traebert M; Novartis BioMedical Research, Postfach, 4002 Basel, Switzerland.; Vargas HM; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA.; Wisialowski TA; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE

Boulay E; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada.; Authier S; Charles River Laboratories, Laval, Quebec, Canada; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada. Electronic address: simonauthier@hotmail.com.; Bartko T; Labcorp Early Development Laboratories Inc, Madison, WI, USA.; Greiter-Wilke A; Roche Pharma Research and Early Development, Basel, Switzerland.; Leishman D; Eli Lilly and Company, Indianapolis, IN, USA.; Li D; Pfizer, Inc, Groton, CT, USA.; Nichols JV; Labcorp Early Development Laboratories Inc, Madison, WI, USA.; Pierson J; Health and Environmental Sciences Institute (HESI), Washington, DC, USA.; Rossman EI; GSK, King of Prussia, PA, USA.; Valentin JP; UCB Biopharma SPRL, Brussels, Belgium.; Vicente J; Center for Drug Evaluation and Research, US Food & Drug Administration (FDA), Silver Spring, MD, USA.; Walisser J; Labcorp Early Development Laboratories Inc, Madison, WI, USA.; Troncy E; GREPAQ (Groupe de recherche en pharmacologie animale du Québec), Université de Montréal, St-Hyacinthe, Québec, Canada.; Wisialowski TA; Pfizer, Inc, Groton, CT, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE

Wisialowski TA; Pfizer, Groton, CT, USA. Electronic address: todd.a.wisialowski@pfizer.com.; Ether N; Amgen Inc., Thousand Oaks, CA, USA.; Foley CM; AbbVie, North Chicago, IL, USA.; Kleiman R; Clario, Philadelphia, PA, USA.; Koshman Y; AbbVie, North Chicago, IL, USA.; Leishman D; Eli Lilly and Company, Indianapolis, IN, USA.; Martel E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Nichols JV; Labcorp, Madison, WI, USA.; Popp J; Labcorp, Madison, WI, USA.; Rajamani S; Johnson & Johnson Innovative Medicine, CA, USA.; Riley S; Pfizer, Groton, CT, USA.; Rossman EI; GSK, Collegeville, PA, USA.; Vargas HM; Amgen Inc., Thousand Oaks, CA, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE

Vargas HM; Translational Safety & Bioanalytical Sciences, Amgen Research, Thousand Oaks, California, USA.; Rolf MG; Research & Development, Clinical Pharmacology & Safety Sciences, AstraZeneca, Gothenburg, Sweden.; Wisialowski TA; Global Safety Pharmacology, Pfizer Global Research and Development, Groton, Connecticut, USA.; Achanzar W; BMS Bristol-Myers Squibb Company, Princeton, New Jersey, USA.; Bahinski A; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Bass A; Merck & Co., Inc., Boston, Massachusetts, USA.; Benson CT; Eli Lilly and Company, Indianapolis, Indiana, USA.; Chaudhary KW; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Couvreur N; Safety Pharmacology, Institute de Recherches Servier, Suresnes, France.; Dota C; Research & Development, Chief Medical Officer Organization, AstraZeneca, Gothenburg, Sweden.; Engwall MJ; Translational Safety & Bioanalytical Sciences, Amgen Research, Thousand Oaks, California, USA.; Michael Foley C; Integrative Pharmacology, Abbvie, Inc, North Chicago, Illinois, USA.; Gallacher D; Global Safety Pharmacology, Janssen Research & Development, Beerse, Belgium.; Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Guillon JM; Sanofi R&D, Preclinical Safety, Paris, France.; Guth B; Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Himmel HM; Safety Pharmacology, Bayer AG, Wuppertal, Germany.; Hegele-Hartung C; Safety Pharmacology, Bayer AG, Wuppertal, Germany.; Ito M; Japan Pharmaceutical Manufacturers Association, Tokyo, Japan.; Jenkinson S; Global Safety Pharmacology, Pfizer Global Research and Development, San Diego, California, USA.; Chiba K; Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Lagrutta A; Merck & Co., Inc., West Point, Pennsylvania, USA.; Levesque P; BMS Bristol-Myers Squibb Company, Princeton, New Jersey, USA.; Martel E; Department of Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.; Okai Y; Takeda Pharmaceutical Company Ltd., Fujisawa, Kanagawa, Japan.; Peri R; Takeda Pharmaceutical Company Ltd., Cambridge, Massachusetts, USA.; Pointon A; Research & Development, Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, UK.; Qu Y; Translational Safety & Bioanalytical Sciences, Amgen Research, Thousand Oaks, California, USA.; Teisman A; Global Safety Pharmacology, Janssen Research & Development, Beerse, Belgium.; Traebert M; Safety Pharmacology, Novartis Institute of Biomedical Research, Basel, Switzerland.; Yoshinaga T; Global Cardiovascular Assessment, Eisai Co., Ltd., Tokyo, Japan.; Gintant GA; Integrative Pharmacology, Abbvie, Inc, North Chicago, Illinois, USA.; Leishman DJ; Eli Lilly and Company, Indianapolis, Indiana, USA.; Valentin JP; UCB Biopharma SPRL, Braine-l'Alleud, Belgium.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Rossman EI; GSK, Nonclinical Safety, Safety Pharmacology, Collegeville, PA, USA. Electronic address: eric.i.rossman@gsk.com.; Wisialowski TA; Pfizer Worldwide Research Development and Medical, Safety Pharmacology, Groton, CT, USA.; Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA.; Valentin JP; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.; Rolf MG; AstraZeneca, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden.; Roche BM; Charles River Laboratories, Global Safety Pharmacology, Ashland, OH, USA.; Riley S; Pfizer Worldwide Research Development and Medical, Clinical Pharmacology, Groton, CT, USA.; Pugsley MK; Cytokinetics, Toxicology, South San Francisco, CA, USA.; Nichols J; Labcorp Early Development Laboratories Inc., Madison, WI, USA.; Li D; Pfizer Global Product Development, Global Biometrics & Data Management, Groton, CT, USA.; Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA.; Kleiman RB; Clario, Philadelphia, PA, USA.; Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Gintant GA; NuPharma Consulting, LLC, USA.; Engwall MJ; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA, USA.; Delaunois A; UCB Biopharma SRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.; Authier S; Charles River Laboratories, Laval, QC, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE

Vargas HM; Amgen Research, Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA. Electronic address: hvargas@amgen.com.; Rossman EI; GlaxoSmithKline, Collegeville, PA 19426, USA.; Wisialowski TA; Pfizer Worldwide Research, Development and Medical, Safety Pharmacology, Groton, CT, USA.; Nichols J; Labcorp Early Development Laboratories Inc., Madison, WI, USA.; Pugsley MK; Cytokinetics, Toxicology, South San Francisco, CA, USA.; Roche B; Charles River Laboratories, Global Safety Pharmacology, Ashland, OH, USA.; Gintant GA; NuPharma Consulting, LLC, USA.; Greiter-Wilke A; Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Kleiman RB; Clario, Philadelphia, PA, USA.; Valentin JP; UCB Biopharma SPRL, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium.; Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE

Li Z; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Mirams GR; Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK.; Yoshinaga T; Global Cardiovascular Assessment, Eisai Co., Ltd., Tokyo, Japan.; Ridder BJ; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Han X; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Chen JE; Division of Biometrics VI, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Stockbridge NL; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Wisialowski TA; Global Safety Pharmacology, Pfizer, Inc., Groton, Connecticut, USA.; Damiano B; Global Safety Pharmacology/Nonclinical Safety, Janssen Research & Development, Raritan, New Jersey, USA.; Severi S; Department of Electrical, Electronic, and Information Engineering, University of Bologna, Cesena, Italy.; Morissette P; Department of Safety Assessment and Laboratory Animal Resources, Merck & Co., Kenilworth, New Jersey, USA.; Kowey PR; Main Line Health and Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.; Holbrook M; Certara, Ltd., Sheffield, UK.; Smith G; Clyde Biosciences Ltd, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, Glasgow University, Glasgow, UK.; Rasmusson RL; Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.; Liu M; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.; Song Z; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.; Qu Z; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.; Leishman DJ; Department of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, Indiana, USA.; Steidl-Nichols J; Covance Inc., Madison, Wisconsin, USA.; Rodriguez B; Department of Computer Science, University of Oxford, Oxford, UK.; Bueno-Orovio A; Department of Pharmacology, University of California Davis, Davis, California, USA.; Zhou X; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; Passini E; Department of Computer Science, University of Oxford, Oxford, UK.; Edwards AG; Department of Pharmacology, University of California Davis, Davis, California, USA.; Morotti S; Department of Pharmacology, University of California Davis, Davis, California, USA.; Ni H; Department of Pharmacology, University of California Davis, Davis, California, USA.; Grandi E; Department of Pharmacology, University of California Davis, Davis, California, USA.; Clancy CE; Department of Pharmacology, University of California Davis, Davis, California, USA.; Vandenberg J; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia.; Hill A; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia.; Nakamura M; Clinical Pharmacology Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.; Singer T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Polonchuk L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Greiter-Wilke A; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Wang K; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Nave S; Roche Product Development, Safety Science/Licensing & Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Fullerton A; Department of Safety Assessment, Genentech, Inc., South San Francisco, California, USA.; Sobie EA; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Paci M; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Musuamba Tshinanu F; Federal Agency for Medicines and Health Products, Brussels, Belgium.; European Medicines Agency, Amsterdam, The Netherlands.; Strauss DG; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Sathish JG; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Pearl River, NY, USA.; Bhatt S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; DaSilva JK; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Flynn D; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Jenkinson S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.; Kalgutkar AS; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.; Liu M; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.; Manickam B; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Pinkstaff J; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.; Reagan WJ; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Shirai N; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Shoieb AM; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Sirivelu M; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.; Vispute S; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Vitsky A; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, San Diego, CA, USA.; Walters K; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Wisialowski TA; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Groton, CT, USA.; Updyke LW; Pfizer Worldwide Research, Development and Medical, 105623Pfizer Inc, Cambridge, MA, USA.

Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

Gosink MM; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Chapin RE; Preston, Connecticut 06365.; Wilkie D; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Davenport S; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Kumpf SW; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Enerson BE; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Houle C; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Koza-Taylor P; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Wisialowski TA; Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340.; Lawton MP; Westbrook, Connecticut 06498.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE

Swanson TA; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Conte T; FUJIFILM VisualSonics, Inc., Toronto, Ontario, Canada.; Deeley B; FUJIFILM VisualSonics, Inc., Toronto, Ontario, Canada.; Portugal S; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Kreeger JM; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Obert LA; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Joseph EC; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Wisialowski TA; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Sokolowski SA; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Rief C; Pfizer Worldwide Research and Development, Andover, Massachusetts, USA.; Nugent P; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Lawton MP; Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Enerson BE; Pfizer Worldwide Research and Development, Groton, Connecticut, USA bradley.e.enerson@pfizer.com.

Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE

Fossa AA; Department of Global Safety Pharmacology, Department of Pharmacokinetics, Dynamics & Metabolism, and Neuroscience, Pfizer Global Research and Development Eastern Point Road, Groton, CT 06340, USA. anthony.fossa@icardiac.com; Wisialowski TA; Cremers T; van der Hart M; Tseng E; Deng S; Rollema H; Wang EQ

Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE

Wikswo JP Jr; Department of Physics and Astronomy, Vanderbilt University, Nashville, TN 37235.; Wisialowski TA; Altemeier WA; Balser JR; Kopelman HA; Roden DM

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print Cited Medium: Print ISSN: 0009-7330 (Print) Linking ISSN: 00097330 NLM ISO Abbreviation: Circ Res Subsets: MEDLINE